People · Operator

Farzad Shawn Nazem

Named in public records as an officer, director or promoter · active 2010–2012 · Other Technology

1
Companies
2
Filings
$46.7M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Apixio Inc.Other TechnologySeries B$46.7M$152.3M2010
Operator network

Farzad Shawn Nazem at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Jared Kesselheim · 7 companies · 1 sharedJared KesselheimJames Bradley · 6 companies · 1 sharedJames BradleyERIC SHUEY · 4 companies · 1 sharedERIC SHUEYCasey West · 3 companies · 1 sharedCasey WestShahin Hedayat · 3 companies · 1 sharedShahin HedayatFarzad Nazem · 2 companies · 1 sharedFarzad NazemPetro Estakhri · 2 companies · 1 sharedPetro EstakhriDarren Schulte · 1 companies · 1 sharedDarren SchulteImran Chaudhri · 1 companies · 1 sharedImran ChaudhriImran Chaudri · 1 companies · 1 sharedImran ChaudriJeff Harmon · 1 companies · 1 sharedJeff HarmonJoel Portice · 1 companies · 1 sharedJoel PorticeSachin Patel · 1 companies · 1 sharedSachin PatelShahram Dastmalchi · 1 companies · 1 sharedShahram DastmalchiShahram Shawn Dastmalchi · 1 companies · 1 sharedShahram Shawn Das…Apixio Inc. · $46.7M raisedApixio Inc.Farzad Shawn NazemFN
Farzad Shawn Nazem Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Farzad Shawn Nazem on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Jared Kesselheim17
James Bradley16
ERIC SHUEY14
Casey West13
Shahin Hedayat13
Farzad Nazem12
Petro Estakhri12
Joel Portice11
Sachin Patel11
Imran Chaudhri11
Shahram Shawn Dastmalchi11
Imran Chaudri11
Shahram Dastmalchi11
Darren Schulte11
Jeff Harmon11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.